The prognosis of breast cancer patients with bone metastasis could be potentially estimated based on blood routine test and biochemical examination at admission

AbstractPurpose Due to the poor and unpredictable prognosis of breast cancer (BC) patients with bone metastasis, it is necessary to find convenient and available prognostic predictors. This study aimed to recognize the clinical and prognostic factors related to clinical laboratory examination and to...

Full description

Bibliographic Details
Main Authors: Bo Huang, Fang-Cai Wu, Wei-Dong Wang, Bu-Qing Shao, Xiao-Mei Wang, Ying-Miao Lin, Guo-Xing Zheng, Ming-Ming Dong, Can-Tong Liu, Yi-Wei Xu, Xin-Jia Wang
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Annals of Medicine
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2023.2231342
_version_ 1797353709821231104
author Bo Huang
Fang-Cai Wu
Wei-Dong Wang
Bu-Qing Shao
Xiao-Mei Wang
Ying-Miao Lin
Guo-Xing Zheng
Ming-Ming Dong
Can-Tong Liu
Yi-Wei Xu
Xin-Jia Wang
author_facet Bo Huang
Fang-Cai Wu
Wei-Dong Wang
Bu-Qing Shao
Xiao-Mei Wang
Ying-Miao Lin
Guo-Xing Zheng
Ming-Ming Dong
Can-Tong Liu
Yi-Wei Xu
Xin-Jia Wang
author_sort Bo Huang
collection DOAJ
description AbstractPurpose Due to the poor and unpredictable prognosis of breast cancer (BC) patients with bone metastasis, it is necessary to find convenient and available prognostic predictors. This study aimed to recognize the clinical and prognostic factors related to clinical laboratory examination and to construct a prognostic nomogram for BC bone metastasis.Methods We retrospectively analyzed 32 candidate indicators from clinical features and laboratory examination data of 276 BC patients with bone metastasis. Univariate and multivariate regression analyses were performed to identify significant prognostic factors related to BC with bone metastasis. Nomogram was constructed and estimated by receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis.Results Patients were randomly grouped into training (n = 197) and validation cohorts (n = 79). In training cohort, the multivariate regression analysis revealed that age, other organ metastasis sites, serum level of lactate dehydrogenase, globulin, white blood cell count, mean corpuscular volume, mean corpuscular hemoglobin, and monocyte ratio were independent prognostic factors for BC with bone metastasis. The prognostic nomogram in training cohort exhibited areas under the ROC curve (AUCs) of 0.797, 0.782, and 0.794, respectively, for predicting 1-, 3-, and 5-year overall survival. In validation cohort, the nomogram still showed acceptable discrimination ability (AUCs: 0.723, 0.742, and 0.704) and calibration.Conclusion This study constructed a novel prognostic nomogram for BC patients with bone metastasis. It could serve as a potential tool of survival assessment to help individual treatment decision-making for clinicians.
first_indexed 2024-03-08T13:34:58Z
format Article
id doaj.art-02c10c677496477a9965a8c199a37809
institution Directory Open Access Journal
issn 0785-3890
1365-2060
language English
last_indexed 2024-03-08T13:34:58Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Annals of Medicine
spelling doaj.art-02c10c677496477a9965a8c199a378092024-01-16T19:13:21ZengTaylor & Francis GroupAnnals of Medicine0785-38901365-20602023-12-0155110.1080/07853890.2023.2231342The prognosis of breast cancer patients with bone metastasis could be potentially estimated based on blood routine test and biochemical examination at admissionBo Huang0Fang-Cai Wu1Wei-Dong Wang2Bu-Qing Shao3Xiao-Mei Wang4Ying-Miao Lin5Guo-Xing Zheng6Ming-Ming Dong7Can-Tong Liu8Yi-Wei Xu9Xin-Jia Wang10Department of Orthopedics, The Cancer Hospital of Shantou University Medical College, Shantou, ChinaDepartment of Radiation Oncology, The Cancer Hospital of Shantou University Medical College, Shantou, ChinaDepartment of Orthopedics, The Cancer Hospital of Shantou University Medical College, Shantou, ChinaDepartment of Clinical Laboratory Medicine, The Cancer Hospital of Shantou University Medical College, Shantou, ChinaDepartment of Clinical Laboratory Medicine, The Cancer Hospital of Shantou University Medical College, Shantou, ChinaDepartment of Clinical Laboratory Medicine, The Cancer Hospital of Shantou University Medical College, Shantou, ChinaDepartment of Orthopedics, The Cancer Hospital of Shantou University Medical College, Shantou, ChinaDepartment of Orthopedics, The Cancer Hospital of Shantou University Medical College, Shantou, ChinaEsophageal Cancer Prevention and Control Research Center, the Cancer Hospital of Shantou University Medical College, Shantou, ChinaEsophageal Cancer Prevention and Control Research Center, the Cancer Hospital of Shantou University Medical College, Shantou, ChinaDepartment of Orthopedics, The Cancer Hospital of Shantou University Medical College, Shantou, ChinaAbstractPurpose Due to the poor and unpredictable prognosis of breast cancer (BC) patients with bone metastasis, it is necessary to find convenient and available prognostic predictors. This study aimed to recognize the clinical and prognostic factors related to clinical laboratory examination and to construct a prognostic nomogram for BC bone metastasis.Methods We retrospectively analyzed 32 candidate indicators from clinical features and laboratory examination data of 276 BC patients with bone metastasis. Univariate and multivariate regression analyses were performed to identify significant prognostic factors related to BC with bone metastasis. Nomogram was constructed and estimated by receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis.Results Patients were randomly grouped into training (n = 197) and validation cohorts (n = 79). In training cohort, the multivariate regression analysis revealed that age, other organ metastasis sites, serum level of lactate dehydrogenase, globulin, white blood cell count, mean corpuscular volume, mean corpuscular hemoglobin, and monocyte ratio were independent prognostic factors for BC with bone metastasis. The prognostic nomogram in training cohort exhibited areas under the ROC curve (AUCs) of 0.797, 0.782, and 0.794, respectively, for predicting 1-, 3-, and 5-year overall survival. In validation cohort, the nomogram still showed acceptable discrimination ability (AUCs: 0.723, 0.742, and 0.704) and calibration.Conclusion This study constructed a novel prognostic nomogram for BC patients with bone metastasis. It could serve as a potential tool of survival assessment to help individual treatment decision-making for clinicians.https://www.tandfonline.com/doi/10.1080/07853890.2023.2231342Breast cancerbone metastasisprognosisnomogramblood routine and biochemical examination
spellingShingle Bo Huang
Fang-Cai Wu
Wei-Dong Wang
Bu-Qing Shao
Xiao-Mei Wang
Ying-Miao Lin
Guo-Xing Zheng
Ming-Ming Dong
Can-Tong Liu
Yi-Wei Xu
Xin-Jia Wang
The prognosis of breast cancer patients with bone metastasis could be potentially estimated based on blood routine test and biochemical examination at admission
Annals of Medicine
Breast cancer
bone metastasis
prognosis
nomogram
blood routine and biochemical examination
title The prognosis of breast cancer patients with bone metastasis could be potentially estimated based on blood routine test and biochemical examination at admission
title_full The prognosis of breast cancer patients with bone metastasis could be potentially estimated based on blood routine test and biochemical examination at admission
title_fullStr The prognosis of breast cancer patients with bone metastasis could be potentially estimated based on blood routine test and biochemical examination at admission
title_full_unstemmed The prognosis of breast cancer patients with bone metastasis could be potentially estimated based on blood routine test and biochemical examination at admission
title_short The prognosis of breast cancer patients with bone metastasis could be potentially estimated based on blood routine test and biochemical examination at admission
title_sort prognosis of breast cancer patients with bone metastasis could be potentially estimated based on blood routine test and biochemical examination at admission
topic Breast cancer
bone metastasis
prognosis
nomogram
blood routine and biochemical examination
url https://www.tandfonline.com/doi/10.1080/07853890.2023.2231342
work_keys_str_mv AT bohuang theprognosisofbreastcancerpatientswithbonemetastasiscouldbepotentiallyestimatedbasedonbloodroutinetestandbiochemicalexaminationatadmission
AT fangcaiwu theprognosisofbreastcancerpatientswithbonemetastasiscouldbepotentiallyestimatedbasedonbloodroutinetestandbiochemicalexaminationatadmission
AT weidongwang theprognosisofbreastcancerpatientswithbonemetastasiscouldbepotentiallyestimatedbasedonbloodroutinetestandbiochemicalexaminationatadmission
AT buqingshao theprognosisofbreastcancerpatientswithbonemetastasiscouldbepotentiallyestimatedbasedonbloodroutinetestandbiochemicalexaminationatadmission
AT xiaomeiwang theprognosisofbreastcancerpatientswithbonemetastasiscouldbepotentiallyestimatedbasedonbloodroutinetestandbiochemicalexaminationatadmission
AT yingmiaolin theprognosisofbreastcancerpatientswithbonemetastasiscouldbepotentiallyestimatedbasedonbloodroutinetestandbiochemicalexaminationatadmission
AT guoxingzheng theprognosisofbreastcancerpatientswithbonemetastasiscouldbepotentiallyestimatedbasedonbloodroutinetestandbiochemicalexaminationatadmission
AT mingmingdong theprognosisofbreastcancerpatientswithbonemetastasiscouldbepotentiallyestimatedbasedonbloodroutinetestandbiochemicalexaminationatadmission
AT cantongliu theprognosisofbreastcancerpatientswithbonemetastasiscouldbepotentiallyestimatedbasedonbloodroutinetestandbiochemicalexaminationatadmission
AT yiweixu theprognosisofbreastcancerpatientswithbonemetastasiscouldbepotentiallyestimatedbasedonbloodroutinetestandbiochemicalexaminationatadmission
AT xinjiawang theprognosisofbreastcancerpatientswithbonemetastasiscouldbepotentiallyestimatedbasedonbloodroutinetestandbiochemicalexaminationatadmission
AT bohuang prognosisofbreastcancerpatientswithbonemetastasiscouldbepotentiallyestimatedbasedonbloodroutinetestandbiochemicalexaminationatadmission
AT fangcaiwu prognosisofbreastcancerpatientswithbonemetastasiscouldbepotentiallyestimatedbasedonbloodroutinetestandbiochemicalexaminationatadmission
AT weidongwang prognosisofbreastcancerpatientswithbonemetastasiscouldbepotentiallyestimatedbasedonbloodroutinetestandbiochemicalexaminationatadmission
AT buqingshao prognosisofbreastcancerpatientswithbonemetastasiscouldbepotentiallyestimatedbasedonbloodroutinetestandbiochemicalexaminationatadmission
AT xiaomeiwang prognosisofbreastcancerpatientswithbonemetastasiscouldbepotentiallyestimatedbasedonbloodroutinetestandbiochemicalexaminationatadmission
AT yingmiaolin prognosisofbreastcancerpatientswithbonemetastasiscouldbepotentiallyestimatedbasedonbloodroutinetestandbiochemicalexaminationatadmission
AT guoxingzheng prognosisofbreastcancerpatientswithbonemetastasiscouldbepotentiallyestimatedbasedonbloodroutinetestandbiochemicalexaminationatadmission
AT mingmingdong prognosisofbreastcancerpatientswithbonemetastasiscouldbepotentiallyestimatedbasedonbloodroutinetestandbiochemicalexaminationatadmission
AT cantongliu prognosisofbreastcancerpatientswithbonemetastasiscouldbepotentiallyestimatedbasedonbloodroutinetestandbiochemicalexaminationatadmission
AT yiweixu prognosisofbreastcancerpatientswithbonemetastasiscouldbepotentiallyestimatedbasedonbloodroutinetestandbiochemicalexaminationatadmission
AT xinjiawang prognosisofbreastcancerpatientswithbonemetastasiscouldbepotentiallyestimatedbasedonbloodroutinetestandbiochemicalexaminationatadmission